Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.86 $3.19 Thursday, 9th May 2024 ATHE stock ended at $2.00. This is 1.96% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 8.63% from a day low at $1.90 to a day high of $2.06.
90 days $1.55 $3.19
52 weeks $1.55 $5.41

Historical Alterity Therapeutics Limited prices

Date Open High Low Close Volume
Aug 07, 2018 $1.98 $1.98 $1.92 $1.97 8 846
Aug 06, 2018 $1.95 $2.02 $1.95 $2.00 10 576
Aug 03, 2018 $2.02 $2.02 $1.95 $1.95 18 635
Aug 02, 2018 $2.07 $2.08 $1.95 $2.00 37 583
Aug 01, 2018 $2.04 $2.12 $2.04 $2.07 6 729
Jul 31, 2018 $2.12 $2.12 $2.02 $2.02 13 193
Jul 30, 2018 $2.12 $2.19 $2.06 $2.11 11 614
Jul 27, 2018 $2.10 $2.12 $2.08 $2.08 16 939
Jul 26, 2018 $2.11 $2.18 $2.10 $2.18 4 887
Jul 25, 2018 $2.16 $2.19 $2.15 $2.16 4 237
Jul 24, 2018 $2.30 $2.30 $2.20 $2.20 5 295
Jul 23, 2018 $2.23 $2.30 $2.18 $2.30 1 423
Jul 20, 2018 $2.26 $2.26 $2.15 $2.22 6 957
Jul 19, 2018 $2.24 $2.25 $2.18 $2.24 5 413
Jul 18, 2018 $2.29 $2.29 $2.20 $2.23 7 735
Jul 17, 2018 $2.26 $2.32 $2.20 $2.20 4 749
Jul 16, 2018 $2.26 $2.34 $2.20 $2.21 49 569
Click to get the best stock tips daily for free!

About Alterity Therapeutics Limited

Alterity Therapeutics Limited Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company ... ATHE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT